These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3115843

  • 21. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
    Anglés-Cano E, Boutière B, Arnoux D, Masson C, Contant G, Benchimol P, Sampol J.
    Thromb Haemost; 1987 Oct 28; 58(3):843-9. PubMed ID: 3124285
    [Abstract] [Full Text] [Related]

  • 22. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB, McGehee WG, Feinstein DI.
    Thromb Haemost; 1988 Jun 16; 59(3):412-4. PubMed ID: 3142079
    [Abstract] [Full Text] [Related]

  • 23. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
    Estellés A, Dalmau J, Falcó C, Berbel O, Castelló R, España F, Aznar J.
    Thromb Haemost; 2001 Aug 16; 86(2):647-52. PubMed ID: 11522017
    [Abstract] [Full Text] [Related]

  • 24. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M, Zegura B, Guzic-Salobir B, Keber I.
    Wien Klin Wochenschr; 2001 Feb 15; 113(3-4):113-8. PubMed ID: 11253736
    [Abstract] [Full Text] [Related]

  • 25. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 15; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 26. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 15; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 27. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.
    Obes Res; 2002 Aug 15; 10(8):717-25. PubMed ID: 12181379
    [Abstract] [Full Text] [Related]

  • 28. [Haemostatic and fibrinolytic variables in women with anorexia nervosa].
    Sobieszczańska S, Rabe-Jabłońska J.
    Psychiatr Pol; 2005 Aug 15; 39(4):741-59. PubMed ID: 16237979
    [Abstract] [Full Text] [Related]

  • 29. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C, Jie AF, Rijken DC, Verheijen JH.
    Thromb Haemost; 1988 Apr 08; 59(2):329-32. PubMed ID: 3133814
    [Abstract] [Full Text] [Related]

  • 30. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH, Rijken DC, Chang GT, Preston FE, Kluft C.
    Thromb Haemost; 1984 Jul 29; 51(3):396-7. PubMed ID: 6437007
    [Abstract] [Full Text] [Related]

  • 31. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA, Fernández Diaz FJ, Rocha E.
    Thromb Haemost; 1988 Jun 16; 59(3):451-4. PubMed ID: 3142082
    [Abstract] [Full Text] [Related]

  • 32. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED.
    Thromb Haemost; 1986 Feb 28; 55(1):74-7. PubMed ID: 3085268
    [Abstract] [Full Text] [Related]

  • 33. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
    Ragab A, Abousamra NK, Higazy A, Saleh O.
    Lab Hematol; 2008 Feb 28; 14(1):1-6. PubMed ID: 18403313
    [Abstract] [Full Text] [Related]

  • 34. Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man.
    Landin K, Tengborn L, Smith U.
    Thromb Haemost; 1994 Jun 28; 71(6):783-7. PubMed ID: 7974348
    [Abstract] [Full Text] [Related]

  • 35. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
    Brommer EJ, Verheijen JH, Chang GT, Rijken DC.
    Thromb Haemost; 1984 Oct 31; 52(2):154-6. PubMed ID: 6441302
    [Abstract] [Full Text] [Related]

  • 36. Plasminogen activator inhibitor (PAI) in obese men and obese women.
    Cucuianu M, Lanczek M, Roman S.
    Rom J Intern Med; 1993 Oct 31; 31(3):183-92. PubMed ID: 8130756
    [Abstract] [Full Text] [Related]

  • 37. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M, Miyashita C.
    Klin Wochenschr; 1988 Oct 31; 66 Suppl 12():62-7. PubMed ID: 3126347
    [Abstract] [Full Text] [Related]

  • 38. Plasminogen activator inhibitor 1 and insulin levels in various insulin resistance states.
    Scelles V, Raccah D, Alessi MC, Vialle JM, Juhan-Vague I, Vague P.
    Diabete Metab; 1992 Oct 31; 18(1):38-42. PubMed ID: 1563535
    [Abstract] [Full Text] [Related]

  • 39. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED, Akkerman JW, Jansen BG.
    Thromb Haemost; 1986 Jun 30; 55(3):325-9. PubMed ID: 3092389
    [Abstract] [Full Text] [Related]

  • 40. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
    Aillaud MF, Pignol F, Alessi MC, Harle JR, Escande M, Mongin M, Juhan-Vague I.
    Thromb Haemost; 1986 Jun 30; 55(3):330-2. PubMed ID: 3092390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.